Peritonitis in childhood: Clinical relevance of cytokines in the peritoneal exudate

European Journal of Pediatric Surgery

Volumn 16, Issue 2, 2006, Pages 94-99

  Haecker, Frank Martin ^a   Fasler Kan, E ^a   Manasse, C ^a   Fowler, B ^a   Hertel, R ^a   Von Schweinitz, D ^a,b  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Childhood; Cytokines; Perforated appendicitis; Peritonitis; Surgical measures

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; APPENDECTOMY; APPENDIX PERFORATION; ARTICLE; BACTERIAL PERITONITIS; BACTERIUM ISOLATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CONVALESCENCE; DISEASE COURSE; ESCHERICHIA COLI; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; HUMAN TISSUE; MALE; PERITONEAL FLUID; PERITONEUM EXUDATE; POSTOPERATIVE PERIOD; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; QUALITATIVE ANALYSIS;

ADOLESCENT; APPENDECTOMY; APPENDICITIS; ASCITIC FLUID; BACTEREMIA; CHILD; CHILD, PRESCHOOL; DEBRIDEMENT; FEMALE; HUMANS; INTERLEUKIN-10; INTERLEUKIN-6; MALE; PERITONITIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33646459316     PISSN: 09397248     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-924049     Document Type: Article

References (26)

1. Ablan CJ, Olen RN, Dobrin PB, O'Keefe P, Tatarowicz W, Freeark RJ. Efficacy of intraperitoneal antibiotics in the treatment of severe fecal peritonitis. Am J Surg 1991; 162: 453-456
2. Adam U, Ledwon D, Hopt UT. Programmed lavage, a basic method of treatment of diffuse peritonitis. Langenbecks Arch Surg 1997; 382: S18-S21
3. Berger D, Beger HG. Neue Aspekte zur Pathogenese und Behandlung der Sepsis und des septischen Schocks. Chirurg 1991; 62: 783-788
4. Berger D, Buttenschoen K. Management of abdominal sepsis. Langenbecks Arch Surg 1998; 383: 35-43
5. Billing A, Fröhlich D, Ruckdeschel G. The influence of taurolin on defense functions and bacterial growth in human peritonitis. Langenbecks Arch Surg 1992; 377: 180-185
6. Bone RC, Fisher CJ, Clemmer TP, Slotman GJ, Metz CA, Balh RA. Sepsis syndrome: a valid clinical entity. Crit Care Med 1989; 17: 389
7. Bone RC. The sepsis syndrome - definition and general approach to management. Clin Chest Med 1996; 17: 175-181
8. Edmiston CE, Goheen MP, Kornhall S, Jones FE, Condon RE. Fecal peritonitis. Microbial adherence to serosal mesothelium and resistance to peritoneal lavage. World J Surg 1990; 14: 176-183
9. Farthmann EH, Schoeffel U. Principles and limitations of operative management of intraabdominal infections. World J Surg 1990; 14: 210-217
10. Focht J, Noesner K. Spectrum of pathogens and resistance in peritonitis. Langenbecks Arch Surg 1997; 382: S1-S4
11. Goertz G. Local antiseptic and antiendotoxic measures in case of intraabdominal infections. Langenbecks Arch Surg 1997; 382: S37-S41
12. Haecker F-M, Schumacher U, Eiring P, Astfalk W, Stuhldreier G, Werner H. Clinical relevance of Bilophila wadsworthia in acute abdominal pain in children. Zentralbl Kinderchir 1997; 6: 40-48
13. Haecker F-M, Kirschner H-J, Berger D, Astfalk W, Schweizer P. Perforated appendicitis in children: Are "adjuvant" surgical procedures necessary for the treatment of peritonitis? Br J Surg 1997; 84: S4
14. Haecker, F-M, Berger D, Schumacher U, Friess D, Schweizer P. Peritonitis in childhood: aspects of pathogenesis and therapy. Pediatr Surg Int 2000; 16: 182-188
15. Heeg K, Miethke T, Wagner H. Neue Perspektiven zur Pathophysiologie der grampositiven Sepsis. Dt Aerztebl 1995; 92: A1177-1180
16. Holzheimer RG, Schein M, Wittmann DH. Inflammatory response in peritoneal exsudate and plasma of patients undergoing planned relaparotomy of severe secondary peritonitis. Arch Surg 1995; 130: 1314-1320
17. Kleine HO, Beger HG. Endotoxinelimination durch intra- und postoperative Lavage bei diffuser bakterieller Peritonitis. Langenbecks Arch Chir 1988; 373 (Suppl II): 654-656
18. Lally KP, Cruz E, Xue H. The role of anti-tumor necrosis factor-α and interleukin-10 in protecting murine neonates from escherichia coli sepsis. J Pediatr Surg 2000; 35: 852-855
19. Leiboff AR, Soroff HS. The treatment of generalized peritonitis by closed postoperative peritoneal lavage. A critical review of the literature. Arch Surg 1987; 122: 1005-1010
20. Martineau L, Shek PN. Peritoneal cytokine concentrations and survival outcome in an experimental bacterial infusion model of peritonitis. Crit Care Med 2000; 28: 788-794
21. Neugebauer E, Rixen D, Raum M, Schäfer U. Thirty years of anti-mediator treatment in sepsis and septic shock - what have we learned? Langenbecks Arch Chir 1998; 383: 26-34
22. Reith HB. Therapy of peritonitis today: Surgical management and adjuvant therapy strategies. Langenbecks Arch Surg 1997; 382 (Suppl I): S14-S17
23. Riche FC, Cholley BP, Panis Y, Laisne MJ, Briard CG, Graulet AM, Gueris JL, Valleur PD. Inflammatory cytokine response in patients with septic shock secondary to generalized peritonitis. Crit Care Med 2000; 28: 433-437
24. Schoeffel U, Jacobs E, Ruf G, Mierswa F, von Specht BU, Farthmann EH. Intraperitoneal micro-organisms and the severity of peritonitis. Eur J Surg 1995; 161: 501-508
25. Schumacher U, Eiring P, Haecker F-M. Incidence of Bilophila wadsworthia in appendiceal, peritoneal and fecal samples from children. Clin Microbiol Infect 1997; 3: 134-136
26. Staubach KH. Adjuvant therapy of secondary peritonitis by taurolidine may modulare the systemic cytokine-mediated host response. Langenbecks Arch Surg 1997; 382: S26-S30